- Datum11.12.2025
- Uhrzeit17:00 - 17:30 Uhr
- Veranstalter
stock3
PharmaSGP Holding SE Inhaber-Aktien o.N. Aktie
Verkaufen
Kaufen
PharmaSGP Holding SE Inhaber-Aktien o.N. Chart inkl. Chartanalyse
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
PharmaSGP Holding SE Inhaber-Aktien o.N. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Hamburg | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Hamburg)
-0,62 %
Intraday
1,27 %
1 Woche
0,00 %
1 Monat
Passender Service zu PharmaSGP Holding SE Inhaber-Aktien o.N.
Webinar zu PharmaSGP Holding SE Inhaber-Aktien o.N.
Kursinformationen (Hamburg)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)---
- Jahrestief / Hoch (€)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von PharmaSGP Holding SE Inhaber-Aktien o.N.
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| - | 2027 (e) | ||
| - | 2026 (e) | ||
| - | 2025 (e) | ||
| 26.06.2025 | 2024 | 0,05 € | - |
| 27.06.2024 | 2023 | 1,36 € | - |
| 29.06.2023 | 2022 | 0,49 € | - |
| 16.06.2022 | 2021 | 0,45 € | - |
Termine von PharmaSGP Holding SE Inhaber-Aktien o.N.
- Apr23PharmaSGP Holding SE Inhaber-Aktien o.N.Q4 2025 Earnings Release
- Jun2PharmaSGP Holding SE Inhaber-Aktien o.N.Q1 2026 Earnings Release
- Sep24PharmaSGP Holding SE Inhaber-Aktien o.N.Q2 2026 Earnings Release
Beschreibung
PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.
